Assignee
SHANGHAI KING CELL BIOTECHNOLOGY CO LTD
CN·1 granted patent·1 pending application·0 citations·filing 2020–2020
Top patents by PatentIndex Score
2 records- 0146US12486497B2F-genotype mumps virus attenuated strain and construction method therefor and application thereofSHANGHAI KING CELL BIOTECHNOLOGY CO LTD·Filed 2020·Granted Dec 2, 2025·0 cites·9 claims
- 0234US2022404359A1Device for evaluating neurovirulence of mumps virusSHANGHAI KING CELL BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI KING CELL BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →